drugset
drugset / Trial / NCT01870674

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

NCT01870674 ↗

Phase 1 Completed 127 enrolled Yuhan Corporation
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Study to evaluate the safety/tolerability and pharmacokinetics/pharmacodynamics(PK/PD)of YH12852 after oral administration in healthy subjects

Timeline

Start
2013-08
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 1.321 mg —
Subject YH12852 Unknown 0.5 mg Oral
Subject YH12852 Unknown 1 mg Oral
Subject YH12852 Unknown 2 mg Oral
Subject YH12852 Unknown 3 mg Oral
Subject YH12852 Unknown 10 mg Oral

Indications

No indication recorded.